Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane (Q46059531)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane |
scientific article |
Statements
1 reference
Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane (English)
1 reference
Linda T Vahdat
1 reference
Joyce O'Shaughnessy
1 reference
Joanne L Blum
1 reference
Ragene R Rivera
1 reference
Nicole L Meneses
1 reference
Brian Pruitt
1 reference
Carol J Fabian
1 reference
David A Smith
1 reference
Elizabeth Tan-Chiu
1 reference
Jonathan Wright
1 reference
Antoinette R Tan
1 reference
Noshir A Dacosta
1 reference
Ellen Chuang
1 reference
John Smith
1 reference
Dale E Shuster
1 reference
Kumari Chandrawansa
1 reference
Fang Fang
1 reference
Patricia E Cole
1 reference
Simon Ashworth
1 reference
6 April 2009
1 reference
27
1 reference
18
1 reference
2954-2961
1 reference
Identifiers
1 reference